Luxembourg - Re-Imbursed Pharmaceutical Market
Since 2014, Luxembourg Re-Imbursed Pharmaceutical Market was up 4.3points year on year. With 5.8 Percent of Generics in Value in 2019, the country was ranked number 17 among other countries in Re-Imbursed Pharmaceutical Market. Austria lead the ranking with 52.2 Percent of Generics in Value in 2019, that is an increase of 2.8points compared to 2018. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark witnessed the best average annual growth at +6.9points per year, while Slovakia witnessed the worst performance at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 5.80 |
| 2018 | 5.80 |
| 2017 | 5.60 |
| 2016 | 5.60 |
| 2015 | 5.60 |
Download all data from 2008 to 2019
How does Luxembourg rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data | |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data | |
| 16 |
#16
Italy
|
9.40 % | 2019 | +1.1 % | +1.6 % | View data | |
| 17 |
#17
Luxembourg
|
5.80 % | 2019 | +0.0 % | +4.3 % | View data | |